Neuroendocrine Control of Carbohydrate Metabolism

  • Sebastian J. Neggers
  • Aart J. van der LelyEmail author
Reference work entry
Part of the Endocrinology book series (ENDOCR)


The neuroendocrine control of metabolism is of paramount importance for life. The control over appetite and satiety are very important for the brain to sustain homeostasis of the body, its weight, and the metabolic processes within. In the past, not so much attention was payed towards separate control systems in the brain that selectively control uptake and metabolism of the main constituents of food, namely, proteins, carbohydrates, and fat.

This chapter tries to address the complex systems that control metabolism of especially carbohydrates, including the effects of carbohydrate intake on the brain.


Carbohydrate Appetite Addiction Hedonic system Neuroendocrine 


  1. Angelopoulos TJ, Lowndes J, Sinnett S, Rippe JM. Fructose containing sugars at normal levels of consumption do not effect adversely components of the metabolic syndrome and risk factors for cardiovascular disease. Nutrients. 2016;8(4):179. Scholar
  2. Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr. 2009;139(6):1263s–8s. Scholar
  3. Basaranoglu M, Basaranoglu G, Sabuncu T, Senturk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013;19(8):1166–72. Scholar
  4. Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, … Broglio F. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol. 2012;166(5):911–6.
  5. Bizzarri C, Rigamonti AE, Luce A, Cappa M, Cella SG, Berini J, … Salvatoni A. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol. 2010;162(3):499–505. EJE-09-1033 [pii].
  6. Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr. 2013;4(2):220–5. Scholar
  7. Brown RM, Kupchik YM, Spencer S, Garcia-Keller C, Spanswick DC, Lawrence AJ, … Kalivas PW. Addiction-like synaptic impairments in diet-induced obesity. Biol Psychiatry. 2015.
  8. de Wit NJ, Afman LA, Mensink M, Muller M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol. 2012.
  9. Delhanty PJ, Huisman M, Baldeon-Rojas LY, van den Berge I, Grefhorst A, Abribat T, … van der Lely AJ. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J. 2013;27(4):1690–700.
  10. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76(5):911–22.CrossRefPubMedGoogle Scholar
  11. Esler WP, Rudolph J, Claus TH, Tang W, Barucci N, Brown SE, … Sweet LJ. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology. 2007;148(11):5175–85.
  12. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, … Hale JE. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A. 2008;105(17):6320–5.
  13. Hajnal A, Norgren R. Accumbens dopamine mechanisms in sucrose intake. Brain Res. 2001;904(1):76–84.CrossRefPubMedGoogle Scholar
  14. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, … Freemark M. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf). 2008;69(6):911–20. CEN3385 [pii].
  15. Hodgkins C, Frost-Pineda K, Gold MS. Weight gain during substance abuse treatment: the dual problem of addiction and overeating in an adolescent population. J Addict Dis. 2007;26(Suppl 1):41–50. Scholar
  16. Hebebrand J, Albayrak O, Adan R, et al. Eating addiction, rather than food addiction, better captures addictive-like eating behavior. Neurosci Biobehav Rev 2014;47:295–306.Google Scholar
  17. Johnson RJ. Why focus on uric acid? Curr Med Res Opin. 2015;31(Suppl 2):3–7. Scholar
  18. Johnson RJ, Andrews P, Benner SA, Oliver W. Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene. Trans Am Clin Climatol Assoc. 2010;121:295–305; discussion 305–8.Google Scholar
  19. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, … Lanaspa MA. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307–15.
  20. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403–13. Scholar
  21. Kalsner L, Chamberlain SJ. Prader-Willi, Angelman, and 15q11-q13 duplication syndromes. Pediatr Clin N Am. 2015;62(3):587–606. Scholar
  22. Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, … Johnson RJ. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 2016;29:3–8.
  23. Kelishadi R, Mansourian M, Heidari-Beni M. Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition. 2014;30(5):503–10. Scholar
  24. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–60.CrossRefPubMedGoogle Scholar
  25. Kratzer JT, Lanaspa MA, Murphy MN, Cicerchi C, Graves CL, Tipton PA, … Gaucher EA. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci U S A. 2014;111(10):3763–8.
  26. Kuppens RJ, Diene G, Bakker NE, Molinas C, Faye S, Nicolino M, … Hokken-Koelega AC. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome. Endocrine. 2015;50(3):633–42.
  27. Leturque A, Brot-Laroche E, Le Gall M. Carbohydrate intake. Prog Mol Biol Transl Sci. 2012;108:113–27. Scholar
  28. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251–64. Scholar
  29. Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie. 2015;116:17–23. Scholar
  30. Lin WT, Chan TF, Huang HL, Lee CY, Tsai S, Wu PW, … Lee CH. Fructose-rich beverage intake and central adiposity, uric acid, and pediatric insulin resistance. J Pediatr. 2016;171:90–6.e91.
  31. Lindqvist A, Baelemans A, Erlanson-Albertsson C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept. 2008;150:26.CrossRefPubMedGoogle Scholar
  32. Lombardi R, Pisano G, Fargion S. Role of serum uric acid and ferritin in the development and progression of NAFLD. Int J Mol Sci. 2016;17(4):548. Scholar
  33. Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, … Schwarz JM. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring). 2016;24(2):453–60.
  34. Maffeis C, Bonadonna RC, Consolaro A, Vettor R, Banzato C, Silvagni D, … Tato L. Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. Eur J Endocrinol. 2006;154(1):61–8. 154/1/61 [pii].
  35. McCrickerd K, Forde CG. Sensory influences on food intake control: moving beyond palatability. Obes Rev. 2016;17(1):18–29. Scholar
  36. Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, … Driscoll DJ. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155a(5):1040–9.
  37. Ozcan B, Neggers SJ, Miller AR, Yang HC, Lucaites V, Abribat T, … Van der Lely AJ. Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? Eur J Endocrinol. 2013.
  38. Ozcan B, Neggers SJ, Miller AR, Yang HC, Lucaites V, Abribat T, … van der Lely AJ. Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? Eur J Endocrinol. 2014;170(6):799–807.
  39. Parker BA, Doran S, Wishart J, Horowitz M, Chapman IM. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf). 2005;62(5):539–46. CEN2254 [pii]CrossRefGoogle Scholar
  40. Petrie JL, Patman GL, Sinha I, Alexander TD, Reeves HL, Agius L. The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am J Physiol Endocrinol Metab. 2013;305(10):E1255–65. Scholar
  41. Purtell L, Sze L, Loughnan G, Smith E, Herzog H, Sainsbury A, … Viardot A. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides. 2011;45(4):301–7.
  42. Rebollo A, Roglans N, Alegret M, Laguna JC. Way back for fructose and liver metabolism: bench side to molecular insights. World J Gastroenterol. 2012;18(45):6552–9. Scholar
  43. Rippe JM, Angelopoulos TJ. Fructose-containing sugars and cardiovascular disease. Adv Nutr. 2015;6(4):430–9. Scholar
  44. Schalkwijk CG, Stehouwer CD, van Hinsbergh VW. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev. 2004;20(5):369–82. Scholar
  45. Schillinger D, Tran J, Mangurian C, Kearns C. Do sugar-sweetened beverages cause obesity and diabetes? Industry and the manufacture of scientific controversy. Ann Intern Med. 2016;165(12):895–7. Scholar
  46. Schultz W. Neuronal reward and decision signals: from theories to data. Physiol Rev. 2015;95(3):853–951. Scholar
  47. Segal MS, Gollub E, Johnson RJ. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr. 2007;46(7):406–17. Scholar
  48. Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr. 2008;87(5):1194–203.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Stice E, Burger KS, Yokum S. Relative ability of fat and sugar tastes to activate reward, gustatory, and somatosensory regions. Am J Clin Nutr. 2013;98(6):1377–84. Scholar
  50. Sun DQ, Wu SJ, Liu WY, Lu QD, Zhu GQ, Shi KQ, … Zheng MH. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. Expert Opin Ther Targets. 2016;20(3):375–87.
  51. Schillinger D, Tran J, Mangurian C, Kearns C. Do Sugar-Sweetened Beverages Cause Obesity and Diabetes? Industry and the Manufacture of Scientific Controversy. Ann Intern Med 2016;165(12):895–7.Google Scholar
  52. Tan PK, Farrar JE, Gaucher EA, Miner JN. Coevolution of URAT1 and uricase during primate evolution: implications for serum urate homeostasis and gout. Mol Biol Evol. 2016;33(9):2193–200. Scholar
  53. Tappy L, Randin JP, Felber JP, et al. Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol 1986;250(6 Pt 1):E718–E24.Google Scholar
  54. Tappy L, Le KA. Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings? Curr Diab Rep. 2015;15(8):54. Scholar
  55. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908–13. Scholar
  56. Tulloch AJ, Murray S, Vaicekonyte R, Avena NM. Neural responses to macronutrients: hedonic and homeostatic mechanisms. Gastroenterology. 2015;148(6):1205–18. Scholar
  57. Van Name M, Giannini C, Santoro N, Jastreboff AM, Kubat J, Li F, … Caprio S. Blunted suppression of acyl-ghrelin in response to fructose ingestion in obese adolescents: the role of insulin resistance. Obesity (Silver Spring). 2015;23(3):653–61.
  58. Ventura T, Santander J, Torres R, Contreras AM. Neurobiologic basis of craving for carbohydrates. Nutrition. 2014;30(3):252–6. Scholar
  59. Wang J, Dourmashkin JT, Yun R, Leibowitz SF. Rapid changes in hypothalamic neuropeptide Y produced by carbohydrate-rich meals that enhance corticosterone and glucose levels. Brain Res. 1999;848(1–2):124–36.CrossRefPubMedGoogle Scholar
  60. Xue J, Ideraabdullah FY. An assessment of molecular pathways of obesity susceptible to nutrient, toxicant and genetically induced epigenetic perturbation. J Nutr Biochem. 2016;30:1–13. Scholar
  61. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–96.CrossRefPubMedGoogle Scholar
  62. Yki-Jarvinen H. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr Opin Clin Nutr Metab Care. 2010;13(6):709–14. Scholar
  63. Zhang W, Chai B, Li JY, Wang H, Mulholland MW. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology. 2008;149(9):4710–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Internal MedicineErasmus University MCRotterdamThe Netherlands

Personalised recommendations